Clínica Baviera Statistics

Total Valuation

Clínica Baviera has a market cap or net worth of EUR 673.84 million. The enterprise value is 682.65 million.

Market Cap	673.84M
Enterprise Value	682.65M

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	Jun 11, 2025

Share Statistics

Clínica Baviera has 16.01 million shares outstanding.

Current Share Class	16.01M
Shares Outstanding	16.01M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	1.84%
Owned by Institutions (%)	2.41%
Float	2.16M

Valuation Ratios

The trailing PE ratio is 16.57.

PE Ratio	16.57
Forward PE	n/a
PS Ratio	2.41
PB Ratio	6.05
P/TBV Ratio	9.35
P/FCF Ratio	16.09
P/OCF Ratio	10.10
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.62, with an EV/FCF ratio of 16.30.

EV / Earnings	16.79
EV / Sales	2.44
EV / EBITDA	8.62
EV / EBIT	11.95
EV / FCF	16.30

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.55.

Current Ratio	1.19
Quick Ratio	1.19
Debt / Equity	0.55
Debt / EBITDA	0.77
Debt / FCF	1.46
Interest Coverage	39.40

Financial Efficiency

Return on equity (ROE) is 38.50% and return on invested capital (ROIC) is 22.07%.

Return on Equity (ROE)	38.50%
Return on Assets (ROA)	16.84%
Return on Invested Capital (ROIC)	22.07%
Return on Capital Employed (ROCE)	32.25%
Revenue Per Employee	153,671
Profits Per Employee	22,354
Employee Count	1,706
Asset Turnover	1.32
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.36% in the last 52 weeks. The beta is 0.80, so Clínica Baviera's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+50.36%
50-Day Moving Average	36.72
200-Day Moving Average	34.65
Relative Strength Index (RSI)	71.83
Average Volume (20 Days)	9,485

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Clínica Baviera had revenue of EUR 279.53 million and earned 40.66 million in profits. Earnings per share was 2.54.

Revenue	279.53M
Gross Profit	135.23M
Operating Income	57.16M
Pretax Income	57.27M
Net Income	40.66M
EBITDA	79.22M
EBIT	57.16M
Earnings Per Share (EPS)	2.54

Full Income Statement

Balance Sheet

The company has 53.44 million in cash and 61.13 million in debt, giving a net cash position of -7.68 million or -0.48 per share.

Cash & Cash Equivalents	53.44M
Total Debt	61.13M
Net Cash	-7.68M
Net Cash Per Share	-0.48
Equity (Book Value)	111.40M
Book Value Per Share	6.89
Working Capital	10.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 66.74 million and capital expenditures -24.87 million, giving a free cash flow of 41.87 million.

Operating Cash Flow	66.74M
Capital Expenditures	-24.87M
Free Cash Flow	41.87M
FCF Per Share	2.62

Full Cash Flow Statement

Margins

Gross margin is 48.38%, with operating and profit margins of 20.45% and 14.55%.

Gross Margin	48.38%
Operating Margin	20.45%
Pretax Margin	20.49%
Profit Margin	14.55%
EBITDA Margin	28.34%
EBIT Margin	20.45%
FCF Margin	14.98%

Dividends & Yields

This stock pays an annual dividend of 1.57, which amounts to a dividend yield of 3.84%.

Dividend Per Share	1.57
Dividend Yield	3.84%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	64.96%
Buyback Yield	n/a
Shareholder Yield	3.84%
Earnings Yield	6.03%
FCF Yield	6.21%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a